EXPLORE CONNECTIONS
Combining cytotoxic agents with continuous dose levels in seamless phase I-II clinical trials
Follow the relationships that help you find your next source.
Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.